Your browser doesn't support javascript.
loading
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin, Adeleye Oluwatosin; Liu, Wan; Adeshakin, Funmilayo O; Afolabi, Lukman O; Zhang, Mengqi; Zhang, Guizhong; Wang, Lulu; Li, Zhihuan; Lin, Lilong; Cao, Qin; Yan, Dehong; Wan, Xiaochun.
Afiliação
  • Adeshakin AO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, B
  • Liu W; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Adeshakin FO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, B
  • Afolabi LO; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, B
  • Zhang M; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; School of Basic Medical Science, Jinzhou Med
  • Zhang G; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Wang L; Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518036, China.
  • Li Z; Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan 523000, China.
  • Lin L; Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan 523000, China.
  • Cao Q; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Yan D; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, B
  • Wan X; Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China; University of Chinese Academy of Sciences, B
Cell Immunol ; 362: 104286, 2021 04.
Article em En | MEDLINE | ID: mdl-33524739
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coenzima A Ligases / Células Supressoras Mieloides Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coenzima A Ligases / Células Supressoras Mieloides Idioma: En Ano de publicação: 2021 Tipo de documento: Article